BioVaxys Technology Corp. (CSE:BIOV)
Canada · Delayed Price · Currency is CAD 0.2750
+0.0400 (17.02%)
Oct 30, 2025, 3:53 PM EDT
BioVaxys Technology Market Cap
BioVaxys Technology has a market cap or net worth of CAD 8.07 million as of October 31, 2025. Its market cap has decreased by -50.94% in one year.
Market Cap
8.07M
Enterprise Value
8.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.28
Market Cap Chart
Since October 6, 2020, BioVaxys Technology's market cap has decreased from 27.06M to 8.07M, a decrease of -70.18%. That is a compound annual growth rate of -21.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 8.07M | -51.03% |
| Dec 31, 2024 | 16.48M | 127.10% |
| Dec 29, 2023 | 7.26M | -47.89% |
| Dec 30, 2022 | 13.92M | -26.37% |
| Dec 31, 2021 | 18.91M | 32.10% |
| Dec 31, 2020 | 14.32M | -47.09% |
| Oct 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.09B |
| Green Thumb Industries | 2.30B |
| dentalcorp Holdings | 2.18B |
| Trulieve Cannabis | 1.89B |
| Sienna Senior Living | 1.81B |
| Extendicare | 1.34B |
| Cronos Group | 1.33B |
| WELL Health Technologies | 1.32B |